
Spectrum Pharmaceuticals SPPI
Quartalsbericht 2023-Q1
hinzugefügt 11.05.2023
Spectrum Pharmaceuticals EV 2011-2026 | SPPI
EV Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 158 M | 80.8 M | 463 M | 298 M | 1.11 B | 1.82 B | 362 M | 390 M | 558 M | 584 M | 781 M | 723 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.82 B | 80.8 M | 611 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Regeneron Pharmaceuticals
REGN
|
87.4 B | $ 742.1 | -1.93 % | $ 77.6 B | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
394 B | $ 211.9 | 0.37 % | $ 375 B | ||
|
Replimune Group
REPL
|
625 M | $ 7.26 | -3.71 % | $ 585 M | ||
|
AbCellera Biologics
ABCL
|
1.22 B | $ 3.28 | -2.24 % | $ 980 M | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Rigel Pharmaceuticals
RIGL
|
679 M | $ 26.28 | -0.34 % | $ 473 M | ||
|
Aileron Therapeutics
ALRN
|
4.02 M | - | 10.36 % | $ 9.8 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
Avidity Biosciences
RNA
|
9.93 B | $ 13.07 | -0.23 % | $ 1.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
270 M | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
6.5 B | $ 77.56 | -5.31 % | $ 5.04 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
2.7 B | $ 12.27 | -12.11 % | $ 1.86 B | ||
|
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B | ||
|
SIGA Technologies
SIGA
|
270 M | $ 5.36 | 7.96 % | $ 383 M | ||
|
Silence Therapeutics plc
SLN
|
1.55 B | $ 4.92 | -7.34 % | $ 622 M | ||
|
SELLAS Life Sciences Group
SLS
|
503 M | $ 4.47 | -9.69 % | $ 487 M | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
71.1 M | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
91.4 M | - | - | $ 3.74 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
122 M | $ 1.08 | -1.38 % | $ 22.2 M | ||
|
Enochian Biosciences
ENOB
|
145 M | - | - | $ 40.5 M | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Summit Therapeutics
SMMT
|
11.9 B | $ 16.59 | -3.88 % | $ 12.4 B | ||
|
Spruce Biosciences
SPRB
|
9.21 M | $ 62.07 | -10.19 % | $ 47.6 M |